The developmental competence of an oocyte is its capacity to resume maturation, undergo successful fertilization, and reach the blastocyst stage. This competence is acquired through interaction with somatic cells of the follicle. Cumulus and granulosa cells support oocyte development, while the oocyte influences follicular cell growth and differentiation. Studies suggest that folliclestimulating hormone and luteinizing hormone play an essential role in oocyte competence acquisition through signaling initiated by protein kinases A and C (PKA and PKC) in granulosa cells.
results improve understanding of the pathways underlying the most important changes that occur in the follicle prior to ovulation.
INTRODUCTION
Studies of gene expression in granulosa cells have focused so far primarily on single genes. Recent technological progress in genetic research has made it possible to examine this tissue in all its complexity and thus to provide a more complete picture of gene expression therein. Two gonadotropic hormones, namely follicle-stimulating hormone (FSH) and luteinizing hormone (LH), are considered the principal reproductive hormones in mammals and primarily responsible for the initiation of signaling events in ovarian target cells. FSH is known to be involved in the regulation of genes that inhibit apoptosis, stimulate cell proliferation, and steroid synthesis and initiate cell differentiation [1] . It is generally accepted that this hormone acts mostly through protein kinase A (PKA), while LH sustains differentiation via a similar pathway as the follicle reaches the pre-ovulatory stage. As reviewed by Hunzicker-Dunn and Mayo [2] , despite the high degree of amino acid sequence homology between these two hormones and activating the same secondary messenger, their actions on their respective target genes in granulosa cells are different and contrasting [2] . In addition to the well-documented role of PKA and cyclic AMP in FSH and LH signaling, accumulating evidence from studies of mammalian and avian granulosa cells suggests that the actions of LH could also be predominantly dependent on protein kinase C (PKC) activity [3] [4] [5] [6] . A recent study showed that mice follicles treated with either low or high concentrations of forskolin, a known activator of PKA, exhibited a significantly decreased ovulatory rate compared with follicles treated with human chorionic gonadotropin (hCG) [7] . A few studies showed lines of evidence of the importance of PKC signaling in the regulation of gene expression during follicular development, ovulation, and luteinization especially LH-induced genes such as progesterone receptor (PGR), ADAM metallopeptidase with thrombospondin type 1 motif 1 (ADAMTS-1), synaptosomal-associated protein 25 (SNAP25), protein kinase, CGMP-dependent, type II (PRKG2), and prostaglandin-endoperoxide synthase 2 (PTGS2) [8] [9] [10] . It was reported by Morris and Richards [6] that the induction of the ovarian events, ovulation and luteinization, appears to require activation of A-and C-kinase pathways as well as other changes in cell function. Despite the fact that PKC signaling seems to be an important mediator of LH response in granulosa cells, little is known about its functions and molecular targets.
In order to delineate the roles of the PKA and PKC signal transduction pathways in the control of human granulosa cell proliferation and differentiation, a granulosa-like cell line was treated in culture with forskolin and PMA (phorbol 12-myristate 13-acetate), two known activators of PKA and PKC, respectively. Derived from a stage 3 diagnosed granulosa cell tumor removed from a 63-year-old Japanese woman in 1984, the KGN cell line is believed to have originated from a dominant follicle among antral or preantral stage follicles [11] . Cultured KGN cells have been found to bear functional FSH receptors and other similarities to ovarian granulosa cells in vivo, including cAMP-inducible aromatase expression. Gonadotropin responsiveness makes this cell line attractive for studying ovarian G-protein-coupled-receptor signal transduction [12] . KGN cells were characterized for a C402G mutation in FOXL2 gene which is known to be an important transcription factor involved in proliferation and differentiation in granulosa cells. It was shown to be heterozygous for the mutation and computer modeling suggests that this amino acid substitution (tryptophan for cysteine, C134W) does not disrupt the folding of the FOXL2 forkhead domain and its interactions with DNA or the protein localization [13, 14] . Therefore, KGN line constitutes a readily accessible and unique system for characterizing PKA and PKC signaling pathways in human folliculogenesis using mechanistic experiments.
MATERIALS AND METHODS

Chemicals
The cell-stimulating compounds were 4-androstene-3,17-dione (product A9630), phorbol 12-myristate 13-acetate aka PMA (product P1585), and forskolin aka FSK (product F3917) purchased from Sigma-Aldrich (St. Louis, MO). Each was dissolved in 95% ethanol.
Human granulosa-like tumor cell line (KGN)
The granulosa cell line KGN was purchased from the RIKEN Bioresource Center (Tsukuba, Japan). The cells maintained physiological characteristics of ovarian granulosa cells, including expression of functional FSH receptor and steroidogenic activities [11] . The cells were cultured in DMEM/F12 medium (Life Technologies) supplemented with 10% foetal bovine serum (Corning), 100X PenicillinStreptomycin (10 000 U/ml) (Life Technologies) in an atmosphere of 5% CO 2 /95% O 2 at 37
• C. Research ethics board review was not required for KGN cell line according to Human Research Ethics Committee at Laval University (CÉRUL).
Cell culture KGN cells were thawed on day 1, placed in a cell culture flask (75 cm 3 , Sigma-Aldrich), and subcultured on day 3. Confluence was never over 80%. On day 6, viable cells were placed in a six-well dish at a density of 3 × 10 5 per well in 3 ml of medium and grown for 24 h. For all experimental conditions, the medium was replaced with charcoal-stripped (SVFA) DMEM/F12 containing antibiotics and 100 nmol L −1 of 4-androstene-3,17-dione. The 24-h treatments consisted of adding either ethanol (less than 0.05% of the culture volume) as a control or additional stimulator in ethanol to obtain 10 μmol of FSK L −1 or 0.1 μmol of PMA L −1 . The experiment was repeated four times (four different weeks) for the microarray data and another four times (4 weeks) for validation by RT-qPCR. Total RNA was isolated using TRIzol reagent (Life Technologies) according to the manufacturer's instructions except that the cells were removed using a cell scraper after the 5 min incubation at room temperature. Total RNA integrity and concentration were evaluated on a 2100-Bioanalyzer (Agilent Technologies, Palo Alto, CA) provided with the RNA NanoLab Chip (Agilent Technologies). For hybridization, the samples were amplified linearly. Antisense RNA (aRNA) was produced using the RiboAmp HS RNA amplification kit (Applied Biosystems). After two amplification rounds of 6 h each, the aRNA output was quantified using the NanoDrop ND-1000 (NanoDrop Technologies, Wilmington, DE).
Sample labeling and microarray hybridization
For each sample, 2 μg of aRNA were labeled using the ULS Fluorescent Labeling Kit for Agilent arrays (Cy3-Cy5) (Kreatech Diagnostics, Amsterdam, Netherlands). The labeled product was then purified with the Pico-Pure RNA Isolation Kit. Labeling efficiency was measured using the Nano-Drop ND-1000. Samples from the four biological replicates of each treatment were hybridized on the human gene expression 4 × 44K v2 microarray (Agilent 
Microarray data analysis
The microarray data were subjected to a simple background subtraction, Loess within array normalization, and Quantile between arrays normalization, statistically analyzed using the Limma package in a reference design. Foreground mean intensities and median background intensities were used as well as the technical replicate averages. Differences were considered statistically significant when the P value was less than 0.05. The gene lists from individual comparisons were then analyzed using Ingenuity Pathway Analysis (Ingenuity Systems, Mountain View, CA). All statistically significant genes (P value < 0.05; change > 1.5-fold) were uploaded to the application and each identifier was mapped to its corresponding object in the Ingenuity database. The functional analysis identified the biological functions that were most significant with respect to the molecules in the dataset.
Preparation of complementary DNA and quantitative RT-PCR
Quantitative reverse transcription polymerase chain reaction (RT-PCR) was performed to confirm the microarray analysis results. One microgram of RNA was reverse-transcribed following the manufacturer's recommendations using a q-Script Flex cDNA Synthesis Kit (Quanta Biosciences, Gaithersburg, MD) with oligo-dT primers and the primers listed in Supplemental Table S1 (designed using the IDT PrimerQuest tool at http://www.idtdna.com/primerquest/home/index) (Supplemental Table S1 ). The amplified fragment was sequenced to confirm the specificity of each primer pair. The products were then used to create the standard curve for quantification experiments, with dilutions ranging from 2 × Complementary DNA quantification was performed using LightCycler 480 Software Version 1.5 (Roche Diagnostics) by comparison with the standard curve. PCR specificity was confirmed by melting curve analysis.
Assay for E2 secretion in KGN cells
Estradiol secretion in KGN cells was determined by quantitating E2 accumulation in the culture medium and the experiment was repeated three times. KGN cells were plated in a six-well dish at a density of 3 × 10 5 per well in 3 ml of medium and grown for 24 h. Then KGN cells were incubated with the same treatments as described above (control, FSK, PMA). The media were collected after 24 h, and E2 concentration was measured using an estradiol radioimmunoassay kit (Cayman, Ann Arbor, MI) according to the manufacturer's protocol. The intra-assay CV for E2 was 6.67% for cell culture media and data were normalized with genomic DNA amount for each sample.
Statistical analysis of quantitative RT-PCR results
For each gene tested, four new biological replicates were used. Analysis of gene expression stability over treatments was performed using GeNorm [15] . The most stable reference genes were identified by the stepwise exclusion of the least stable gene and recalculating the M values. Following GeNorm analysis, peptidylprolyl isomerase A (PPIA), tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ), glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were the most stable genes, based on M values < 1.5 as recommended by the software (M value = 0.640). Data are presented as mean ± SEM. ANOVA validity was based on testing for homogeneity of variances and normality using SAS software. Each treatment mean was compared to the control using a Dunnett test. Statistical analysis was conducted with SAS University Edition software on log 10 -transformed values.
RESULTS
Microarray data analysis
Data normalization and cut-offs at a symmetrical change of 1.5-fold and at P value of 0.05 revealed 2571 genes expressed differentially in response to FSK or PMA treatment, including 537 for both treatments, 978 for FSK only, and 1056 for PMA only.
Upstream regulators
Ingenuity Pathway Analysis software highlighted the major upstream and signaling pathways involved in each treatment and allowed a functional classification of targeted genes (Supplemental Data, Tables S3 and S4). Only the top five upstream regulators in common for both treatments were selected for this analysis (Table 1) . After 24 h of stimulation, transforming growth factor beta 1 (TGFβ1), epidermal growth factor (EGF), and basic fibroblast growth factor (FGF2) signaling pathways were shown to be strongly activated by PMA and inhibited or not activated by FSK, while vascular epidermal growth factor (VEGF) showed a clear tendency to be activated by PMA and strongly inhibited by FSK. Hepatocyte growth factor (HGF), believed to be an important factor for granulosa cell differentiation, was strongly activated by PMA and strongly inhibited by FSK.
Functional classification of the targeted genes
Genes that reached the cut-off level of differential expression in response to both treatments were associated with seven major functions involved in normal follicular development (Table 2) . They make up a partial list of all the genes expressed differentially. Gene categorization according to treatment allowed a functional distinction between PKA and PKC signaling pathways (Supplemental Data, Tables S5 and S6) . Differential expression among genes related to cell differentiation appeared mostly as upregulation of known promoters of cell differentiation. Downregulation of caveolin-1 (CAV1) in response to both treatments might amount to upregulation of differentiation functions because of its suspected role as an inhibitor of ovulation and luteinization [16] . Fibronectin 1 (FN1) and fibroblast growth factor 1 (FGF1) were inhibited in response to FSK but activated in response to PMA. A slight majority of the genes promoting differentiation (8 out of 14) were found upregulated following PKC activation only.
Downregulation of cell division and proliferation appeared to follow activation of either PKA or PKC. Downregulation of cycling D1 (CCND1) in response to FSK and upregulation in response to PMA were noted. Upregulation of the gene encoding dexamethasoneinduced Ras-related protein 1 (RASD1) was strong in response to both treatments, changing 33.9-fold downstream from PKA and 7.5-fold downstream from PKC. This gene is associated with cell proliferation and differentiation in other tissues, but its role in the ovary remains to be clarified [17] .
The response in terms of apoptosis was ambivalent, with expression of pro-apoptotic BCL2 associated X (BAX), caspase 1 (CASP1), caspase 4 (CASP4) and anti-apoptotic baculoviral IAP repeat containing 5 (BIRC5), BCL2 like 12 (BCL2L12), inhibin alpha subunit (INHA) genes appearing mutually antagonistic. A certain state of equilibrium is normally required in order to prevent activation of the cell death program. In KGN cell culture, no evidence of apoptosis or cell death was observed in response to either treatments as the phenotype following treatment did not show any differences compared to control after 24 h (data not shown).
The inflammation process (an essential part of follicular development for ovulation, among other processes) is largely represented in the present context as upregulation of interleukins and other ovulation drivers such as PTGS2 (COX2). This category also comprises genes related to leukocyte migration such as vanin 2 (VNN2), which was upregulated in response to PMA, and genes related to extracellular matrix remodeling such as pentraxin 3 (PTX3), which was downregulated in response to FSK [18, 19] . In KGN cells, both PKA and PKC appeared able to mediate an inflammatory response, but results also suggest potentiation of the inflammatory process when both PKA and PKC are activated.
Steroidogenesis is one of the principal functions of granulosa cells. Upregulation of genes such as cholesterol side-chain cleavage enzyme (CYP11A1) and cytochrome P450 family 19 subfamily A member 1 (CYP19A1) was noted in response to FSK. Lipid metabolism genes such as aldo-keto reductase family 1 member B10 (AKR1B10) and steroidogenesis regulation genes such as follistatin (FST) have been associated with PKA activation in KGN cells [20] . Both PKA and PKC mediated the upregulation of steroidogenic acute regulator (STAR), which encodes the rate-limiting enzyme for progesterone production. STAR expression thus increased 9.54-fold in response to FSK and 3.42-fold in response to PMA.
It is widely known that for ovulation to occur, the follicle wall must be weakened and ultimately ruptured by proteases that break down the extracellular matrix and connective tissues. In KGN cells, protease activity appeared to be associated primarily with PKC activation, since expression of matrix metalloproteinase genes (MMPs) and the corresponding specific inhibitor genes (TIMPs) was increased in response to PMA. The plasmin system, which comprises principally two types of plasminogen activators (tissue and urokinase-type, PLAT, PLAU) and also plays a role in ovulation-related proteolysis, was also found to be PKC dependent.
Finally, angiogenesis was also found to be PKC dependent, as upregulation of a majority of the genes reported in this class occurred in response to PMA. Upregulation of both proteolysis and angiogenesis as ovulation nears is well known, which supports our observation that PKC is a very important signaling pathway for follicular development. 
Differentiation
Division Apoptosis Inflammation Steroidogenesis Protease Angiogenesis HEY1  ITGB1  PTX3  MMP10  NRP1  ITGA5  LIF  MMP14  VEGFC  FN1  TIMP1  VEGFA  SPP1  PLAT  TNFAIP2  SPRY4 PLAU THBD PLAUR SERPINA1 Red = upregulation; green = downregulation; parenthesis, red = inhibited the corresponding physiological function; parenthesis, green = activated/stimulated the corresponding function. See supplemental data for gene description (Table S2 ).
Validation of protein kinases A and C gene expression patterns
The expression level of 10 candidate genes was compared using RT-PCR as described below (Figure 1 ) in order to validate the microarray expression data. The candidates were chosen to include different physiological functions. Genes associated with proteolysis and found PKC dependent, namely matrix metallopeptidase 9 (MMP9), matrix metallopeptidase 1 (MMP1), tissue inhibitor of metalloproteinase 1 (TIMP1), and also genes related to angiogenesis, namely thrombomodulin (THBD), C-X-C chemokine receptor type 4 (CXCR4), tissue factor pathway inhibitor 2 (TFPI2), were validated and followed the same expression pattern as the microarray data. PKA-dependent steroidogenesis genes encoding cholesterolside-chain cleavage enzyme (CYP11A1), aromatase (CYP19A1), steroidogenic acute regulatory protein (STAR), and cell proliferation gene encoding dexamethasone-induced Ras-related protein 1 (RASD1) also corroborated the microarray data. The expression pattern was statistically consistent with the microarray data for all 10 genes.
Estradiol synthesis
To determine whether FSK stimulation of FSH-regulated steroidogenic enzyme aromatase mRNAs (CYP19A1) also resulted in modulation of granulosa cell estradiol production, media concentration of estradiol (E 2 ) was examined. Following FSK stimulation, media concentrations of E2 were increased (P <0.05) compared to control and cells treated with PMA (Figure 2) .
DISCUSSION
This study reveals the principal target genes and pathways involved in the FSH and LH signaling networks in human granulosa-like cells (KGN), based on changes in expression levels in response to stimulators of protein kinases A and C. As members of the GPCR family, FSH and LH receptors are known to activate adenylyl cyclase through G protein signaling, but also to activate phospholipase C independently, which results in the activation of PKC by hydrolyzing membrane-bound phosphatidylinositol 4,5-bisphosphate (PIP2) to diacylglycerol (DAG) and inositol 1,4,5-triphosphate (IP3). In KGN cells, gonadotropin second messenger activation was mimicked through direct activation of PKA and PKC via stimulation with FSK or phorbol 12-myristate 13-acetate. PKC, which is thought to mediate primarily the LH signaling pathway, was shown in this study to be involved in at least four important signaling pathways related to proliferation, differentiation, luteinization, and ovulation in granulosa cells. The following discussion points out interesting major pathways that are thought to be involved in PKA and PKC signaling pathways based on Ingenuity Pathway Analysis software and provide new insights for further research.
Regulatory role of protein kinase C in proliferation and differentiation of granulosa cells Transforming growth factor beta 1 and epidermal growth factor
The results of this study suggest activation of PKC-dependent EGF and TGFβ1 signaling pathways. EGF and its receptor-signaling pathway constitute one of the most important regulators of mammalian cell growth, survival, proliferation, and differentiation while TGFβ1 is reported to act on steroidogenesis, cell survival, and differentiation. Only a few studies of its functions in human granulosa cells have been published. TGFβ1 is part of the TGF-β superfamily, which is a structurally conserved but diverse group of proteins with about 35 members in vertebrates [21, 22] . TGFB ligands act through the canonical pathway that activates Smad pathways, and activation of TGFβ receptor types I and II (TGFβRI, TGFβRII) also mediate their actions through a noncanonical pathway that includes mitogenactivated protein kinase and phosphoinositide-3-kinase/Akt signaling Smad-independent pathways [23] . EGF acts upstream from ERK, MEK, and RAS-RAF-MEK, which have been shown to be necessary for fertility in mice [24, 25] . ERK1/2 was the first intracellular signaling kinase identified as a differential regulator of FSH-induced progesterone and estradiol synthesis in granulosa cells of rat early antral follicles. Several studies have suggested different regulatory roles for EGF and TGFβ1. Their stimulatory or inhibitory actions depend on species and follicular stage, since granulosa cells do not respond to them the same way in rodents, ruminants, and pigs [22, 26, 27] . However, most studies agree that interaction between these two factors may be important for proper follicular development and gonadotropin-dependent differentiation [28] . Human, swine, and rat studies all suggest that EGF could be acting in an autocrine manner to stimulate proliferation of immature granulosa cells and could stimulate progesterone production by mature granulosa cells in preovulatory follicles while inhibiting estradiol production [29] [30] [31] . As reported by Ostrzenski [32] and many others, EGF in pre-ovulatory follicles is associated with progesterone production, gonadotropin stimulation, and suppressed FSH/cAMP-dependent formation of the LH receptor [33] . In contrast, TGFβ1 appears to stimulate FSHdependent LH receptor formation and to inhibit progesterone production in the ovary [32, 34] . TGFβ1 is thus thought to interfere with the action of EGF by delaying luteinization, thus preventing premature elevation of serum progesterone, which has been associated with decreased implantation and pregnancy rate and increased follicular apoptosis [35] . The literature and our observations of KGN cells both suggest that PKC acts on TGFβ1 signaling and could potentially regulate steroidogenesis acting as a drag on luteinization. PKC could also antagonize estradiol and progesterone production through this factor and thereby limit FSH-stimulated growth and differentiation without completely shutting down the steroidogenic potential of the cells [32] .
According to the literature, modulation of steroidogenesis thus appears to occur via PKC-dependent activation of Smad2/3 and ERK1/2 pathways respectively by TGFβ1 and EGF [21, 36, 37] . The interaction between these factors implies antagonistic effects on the regulation of granulosa cell differentiation.
Basic fibroblast growth factor and epidermal growth factor Another upstream regulator found to be PKC dependent in this study and thought to play an important role in follicular development is fibroblast growth factor 2 (FGF2; fibroblast growth factor 2 (basic)). Among the families of growth factors that influence follicular function, the FGF superfamily is one of the largest [38] . As reviewed previously [39] , this family of ligands includes about 22 members in humans and mice. The most studied of these is FGF2, a nearly ubiquitous member with highly variable expression patterns depending on the cell type. In granulosa cells, FGF2 may be responsible for cell proliferation, prevention of apoptosis, and decreased steroidogenesis [38, 40] . FGF2 is also known to activate PKC apparently through recruitment of the SH2 domain of PLC-y to its receptor, thereby resulting in phosphatidyl inositol hydrolysis and DAG production [39, 41, 42] , and to attenuate FSH-induced differentiation, progesterone production, and estradiol secretion in cultured rat granulosa cells and bovine granulosa cells from pre-antral follicles [27, 43] . Reduction of LH receptor expression in porcine granulosa cells has been reported, suggesting that FGF2 keeps pre-antral somatic cells mitotically active and undifferentiated [43] . FGF2 is thus thought to play a role in follicle development through effects on differentiation, luteinization, and the ovulation process [42] .
Among the known FGF2-targeted genes expressed differentially in this study, sprouty RTK signaling antagonist 2 (SPRY2), which encodes a regulator of tyrosine kinase receptor signals such as FGF2 and EGF, was upregulated in response to both PKC and PKA signaling. Sprouty homologs 2 and 4 (the latter also expressed differentially in KGN cells in response to PKC signaling) might play a role in a FGF2/EGF balancing mechanism that is thought to modulate final maturation of human granulosa cells and regulate angiogenesis in the corpus luteum [44] . EGF signaling in mice can be activated, potentiated, or inhibited by SPRY2 through a signaling loop involving the protein c-CBL [45] . SPRY2 might be partly responsible for downregulation of EGF in luteinized cells of human pre-ovulatory follicles, an event that might be necessary for final maturation since EGF is generally absent in pre-ovulatory follicular fluid [44] .
In bovine studies using suppressive subtractive hybridization, SPRY2 mRNA was identified only in granulosa cells associated with oocytes that yielded blastocysts, not with oocytes that failed to develop [46] . Differential expression of SPRY2 in pre-ovulatory follicles may thus be a marker of ovulatory competence involving PKC signaling in granulosa cells.
Vascular epidermal growth factor and basic fibroblast growth factor
Another important factor-signaling pathway that was inhibited strongly by PKA and activated by PKC is the VEGF. Defined as the physiological process through which new blood vessels form from existing vessels, angiogenesis is an important prerequisite for proper maturation of ovarian follicles. As reported by Gougeon, the pre-ovulatory follicle becomes highly vascularized in the thecal tissue toward the mid-follicular phase, while granulosa tissue remains avascular until the mid-cycle gonadotropin surge [47] . Several hours before ovulation (which occurs about 36 h after the surge), the granulosa wall is invaded by the blood vessels growing from the theca in response to angiogenic factors produced by granulosa cells. After ovulation, as granulosa cells luteinize to form the corpus luteum, the follicle undergoes rapid vascularization [48] .
Angiogenesis takes place regularly in the ovary, where it requires temporal and spatial fine regulation by the balance of pro and antiangiogenic regulators. Granulosa cells of antral follicles appear to produce angiogenic factors even though they stay avascular until ovulation, implying the existence of a regulatory mechanism that prevents premature follicular vascularization [49] . In KGN cells, strong inhibition of VEGF signaling pathways occurred following PKA stimulation, suggesting that this protein kinase and/or cAMP are major among the signals that intervene in this inhibition mechanism. Furthermore, upregulation by PKC of many genes associated with angiogenesis, such as CXCR4, TFPI2, cysteine rich angiogenic inducer 61 (CYR61), angiopoietin like 4 (ANGPTL4), hes related family bHLH transcription factor with YRPW motif 1 (HEY1), neuropilin 1 (NRP1), vascular endothelial growth factor C (VEGFC), vascular endothelial growth factor A (VEGFA), TNF alpha induced protein 2 (TNFAIP2) and so on, provides evidence that angiogenesis signaling in late and pre-ovulatory follicles could be mediated through PKC-driven activation following LH stimulation.
FGF2 is also believed to have angiogenic effects and to be responsible for neovascularization of the corpus luteum. As reported by Seghezzi, FGF2 could work in an autocrine manner on several cell functions required for angiogenesis, including proliferation, migration, proteinase production, and integrin expression [50] . In this study, FGF2 followed the same path as VEGF in terms of activation and inhibition in response to both treatments, thus reinforcing an inhibitory role for PKA and a positive role for PKC on the angiogenesis process in granulosa cells.
Hepatocyte growth factor HGF is another interesting upstream gene product highlighted by Ingenuity upstream analysis. First characterized as a mitogen of adult hepatocytes via the tyrosine kinase receptor c-Met, HGF is now known to stimulate epithelial cell proliferation and motility, angiogenesis and organ morphogenesis, and to act as an anti-apoptotic or anti-inflammatory signal in various organs. Its numerous biological functions have been reviewed and include promoting parenchymal organ generation, development, and maturation as well as tissue regeneration in the liver and other organs following injuries [51] . It was suggested as far back as 1998 that it plays an important role in establishing the differentiation/proliferation axis of granulosa cells by decreasing basal and hormone-stimulated progesterone production and aromatase activity, implying that it acts by inhibiting differentiation and promotion proliferation [52] . This was confirmed in another study using KGN cells, which concluded that HGF plays a major role in preventing premature differentiation of granulosa cells by suppressing progesterone production [53] . It was later determined that HGF and MET proto-oncogene, receptor tyrosine kinase (HGFR) expression was stronger in larger follicles, implying that HGF is an important factor for differentiation prior to ovulation [54] . These studies also related HGF action in granulosa cells to LH stimulation, although the connexion might not be direct. In this study of KGN cells, strong inhibition of HGF in response to PKA activation and strong stimulation following PKC activation supports the hypothesis of LH-dependent signaling for HGF upstream action in granulosa cells.
In myofibroblasts, HGF also appears to induce expression of MMPs (discussed below) and to play an anti-inflammatory role by recruiting of inhibitors of proinflammatory cytokines such as interleukin 6 (IL6) and interleukin a beta (IL1B). It has also been described as an angiogenic factor complementary to VEGF and FGF2 with anti-thrombosis effects [51] .
Finally, HGF has been shown recently to play a key role in follicle developmental competence at various levels including cell survival, ECM organization, inflammatory processes, luteinization, and angiogenesis. Certain genes associated with developmental competence, such as toll-like receptor 2 (TLR2), thrombomodulin (THBD), TGF-beta receptor type-2 (TGFβR2), and phosphodiesterase 8B (PDE8B), have been identified as downstream targets of HGF [55] . HGF and its receptor thus represent an interesting pathway to investigate in order to elucidate the differentiation/maturation process in granulosa cells, a pathway that, based on our results, is activated in a PKC-dependent manner.
The regulatory role of protein kinase C in luteinization and ovulation Although KGN cells are derived from a dominant follicle, genes related to pre-ovulatory follicle physiology were also expressed in this study. Since the affinity of phorbol 12-myristate 13-acetate for PKC is about 250 times higher than that of DAG, it is presumed that it kept the kinase in a permanent state of activation [56] . PKC activation of AREG and EGFR in KGN cells suggests that this kinase promotes EGF-like growth amphiregulin (AREG), betacellulin (BTC), epiregulin (EREG) in pre-ovulatory follicles, since the involvement of these genes in the luteinization and ovulation process is well known [1, 24, 36, [57] [58] [59] .
Other important factors that were activated via PKC in this study are MMPs, plasminogen activators, and specific TIMPs. Metalloproteinase and protease appear to be involved in the shedding of EGF-like growth factors from the granulosa cell membrane under the influence of LH and PKC signaling pathways [1, 24, 60] . It is also reported that metalloproteinase activity can alter the ECM and basal membrane and that the effect on the ECM modulates multiple physiological processes such as growth, proliferation, differentiation atresia, and follicular rupture. Spatial and temporal modulation of MMPs and TIMPs signaling and control of the MMP/TIMP ratio are important for maintaining tissue architecture and normal follicular development. PMA also caused upregulation of serine protease genes such as PLAT and PLAU, which appear to control pericellular proteolysis and degradation of matrix components and to interact with the potential inhibitor serpin family E member 2 (SERPINE2) which has been found upregulated in FSK-treated cells [61] [62] [63] . Although KGN cells are not derived from pre-ovulatory tissue, it is still possible that the principal protease activity in granulosa cells, an activity that supports various processes requiring extracellular matrix remodeling including differentiation and luteinization, is PKC dependent.
Overall, PKA and PKC signaling pathways definitely play an important role in various major functions of ovarian follicle development such as cell differentiation, final maturation, luteinization, and ovulation. The PKC signaling pathway seems to influence steroidogenesis and maturation of granulosa cells largely through inhibitory actions that may or may not also involve PKA [64] [65] [66] . Moreover, four of the five upstream regulators shown to be activated following PKC activation were identified in LH basal signaling and are thought to have an important role in final maturation and the acquisition of developmental competence [67] . Although the KGN cells do not differentiate in a typical pre-ovulatory stage in culture, they represent a good model for the study of the dominant follicular phase and the way granulosa cells try to differentiate under PKC influence. Among genes shown to be regulated by FOXL2 mutant in a recent study, only 24 genes out of the 2571 genes of this study are thought to be affected by the mutation. This suggests that the present results are mainly based on the expression of genes that are not targeted by the FOXL2 transcription factor acknowledging KGN cell line as a good in vitro model for this study [13] . To our knowledge, our explorative study is the first to provide an overall image of PKA and PKC signaling in human granulosa cells. There is now clear evidence that PKC signaling plays a key role in mediating the effect of LH on follicular final maturation and granulosa cell differentiation. In order to reveal how the regulation of gene expression is manifested as biomarkers of follicular development, the main signaling pathways need to be dissected, and this study should be regarded as a reference for further in depth research on selected candidate genes.
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